Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Akebia Therapeutics Inc’s current trading price is -27.42% away from its 52-week high, while its distance from the 52-week low is 125.00%. The stock’s price range during this period has varied between $0.80 and $2.48. The company, active in the Healthcare sector, saw a trading volume of around 3.57 million for the day, considerably higher average daily volume of 2.21 million observed over the last three months.
The stock market performance of Akebia Therapeutics Inc has been very steady. Over the last year, the company’s stock hit its highest at $2.48 on 03/28/24, while the lowest price during the same time frame was $0.80, recorded on 06/26/24.
How Financial Performance Impacts Market Capitalization
Akebia Therapeutics Inc (AKBA) has experienced a quarterly decline of -1.10% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 392.73M and boasts a workforce of 167 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.8606, with a change in price of +0.5200. Similarly, Akebia Therapeutics Inc recorded 2,142,472 in trading volume during the last 100 days, posting a change of +40.63%.
AKBA Stock Stochastic Average
As of today, the raw stochastic average of Akebia Therapeutics Inc over the past 50 days is 12.23%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 9.84%. Additionally, the Stochastic %K and %D values for the company were 9.14% and 6.93%, respectively, over the past 20 days.
AKBA Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -5.26% this year. Over the last six months, there has been a weaker performance of 17.65%. The price of AKBA leaped by -21.74% during the last 30 days period. For the last 5-days stocks have slided -9.09%.
